LRA by ELISA/ACT
ELISA/ACT Biotechnologies (EAB) is the exclusive provider of the lymphocyte response assay (LRA by ELISA/ACT®) tests – the gold standard in delayed hypersensitivity testing.
Built on a strong foundation of patented technology, patient-friendly guidance, value-added support, and proven results, EAB will provide you with a successful plan to determine and address the causes of chronic disease and immune system dysfunction and restore overall health.
Click here to read more about LRA testing on ELISA/ACT’s website